Exhibit 99
Form 4 Joint Filer Information
|
Name: |
Mark Lappe |
|
|
|
|
Address: |
11622 El Camino Real, Suite 100 |
|
|
San Diego, CA 92130 |
|
|
|
|
Designated Filer: |
Efficacy Capital Ltd. |
|
|
|
|
Issuer & Ticker Symbol: |
Repros Therapeutics Inc. (RPRX) |
|
|
|
|
Date of Event Requiring Statement: |
10/17/2008 |
|
|
|
|
Signature |
s/ Mark Lappe |
|
|
|
|
|
|
|
Name: |
Jon Faiz Kayyem |
|
|
|
|
Address: |
11622 El Camino Real, Suite 100 |
|
|
San Diego, CA 92130 |
|
|
|
|
Designated Filer: |
Efficacy Capital Ltd. |
|
|
|
|
Issuer & Ticker Symbol: |
Repros Therapeutics Inc. (RPRX) |
|
|
|
|
Date of Event Requiring Statement: |
10/17/2008 |
|
|
|
|
Signature |
s/ Jon Faiz Kayyem |
|
Name: |
Efficacy Capital Ltd. |
|
|
|
|
|
|
Address: |
11622 El Camino Real, Suite 100 |
|
|
|
San Diego, CA 92130 |
|
|
|
|
|
|
Designated Filer: |
Efficacy Capital Ltd. |
|
|
|
|
|
|
Issuer & Ticker Symbol: |
Repros Therapeutics Inc. (RPRX) |
|
|
|
|
|
|
Date of Event Requiring Statement: |
10/17/2008 |
|
|
|
|
|
|
Signature |
Efficacy Capital Ltd. |
|
|
|
|
|
|
|
By: |
s/ Mark Lappe |
|
|
Managing Partner |
|
|
|
|
|
|
|
|
|
|
Name: |
Efficacy Biotech Fund L.P. |
|
|
|
|
|
|
Address: |
11622 El Camino Real, Suite 100 |
|
|
|
San Diego, CA 92130 |
|
|
|
|
|
|
Designated Filer: |
Efficacy Capital Ltd. |
|
|
|
|
|
|
Issuer & Ticker Symbol: |
Repros Therapeutics Inc. (RPRX) |
|
|
|
|
|
|
Date of Event Requiring Statement: |
10/17/2008 |
|
|
|
|
|
|
Signature |
Efficacy Capital Ltd., Investment Manager |
|
|
|
|
|
|
|
By: |
s/ Mark Lappe |
|
|
Managing Partner |
|
|
Name: |
Efficacy Biotech Fund Limited |
|
|
|
|
|
|
Address: |
11622 El Camino Real, Suite 100 |
|
|
|
San Diego, CA 92130 |
|
|
|
|
|
|
Designated Filer: |
Efficacy Capital Ltd. |
|
|
|
|
|
|
Issuer & Ticker Symbol: |
Repros Therapeutics Inc. (RPRX) |
|
|
|
|
|
|
Date of Event Requiring Statement: |
10/17/2008 |
|
|
|
|
|
|
Signature |
Efficacy Capital Ltd., Investment Manager |
|
|
|
|
|
|
|
By: |
s/ Mark Lappe |
|
|
Managing Partner |
|
|
Name: |
Efficacy Biotech Master Fund Ltd. |
|
|
|
|
|
|
Address: |
11622 El Camino Real, Suite 100 |
|
|
|
San Diego, CA 92130 |
|
|
|
|
|
|
Designated Filer: |
Efficacy Capital Ltd. |
|
|
|
|
|
|
Issuer & Ticker Symbol: |
Repros Therapeutics Inc. (RPRX) |
|
|
|
|
|
|
Date of Event Requiring Statement: |
10/17/2008 |
|
|
|
|
|
|
Signature |
Efficacy Capital Ltd., Investment Manager |
|
|
|
|
|
|
|
By: |
s/ Mark Lappe |
|
|
Managing Partner |
|